Achievements｜Department of Virology, Institute of Tropical Medicine, Nagasaki University

Articles/Books

2021-11-03

Elizabeth Ajema Chebichi Luvai, Leo Uchida, Mya Myat Ngwe Tun, et al.

Seroepidemiological surveys of tick-borne encephalitis virus and novel tick-borne viruses in wild boar in Nagasaki, Japan

Articles/Books

2021-10-08

Hidetoshi Nomoto, Masahiro Ishikane, Sangnim Lee, et al.

Facilitating the deployment of Japanese human resources for responding global outbreaks of emerging and Re-emerging infectious diseases: A cross-sectional study

Presentations

2021-09-29

Thi Thanh Ngan Nguyen

Pre-existing neutralizing activity to SARS-CoV-2 in Vietnam prior to COVID-19 pandemic, 2014-2019.

Presentations

2021-09-29

Sandra Kendra Raini

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.

Presentations

2021-09-29

Elizabeth Ajema Chebichi Luvai,

Evidence of Chikungunya virus seroprevalence in Myanmar among Dengue suspected patients and healthy volunteers in the years 2013, 2015 and 2018.

Presentations

2021-09-11

Jean Claude Balingit

A simple and high-throughput alternative virus assay in the serologic diagnosis of mosquito-borne flavivirus infections.

Presentations

2021-09-11

Mizuki Fukuta

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

Presentations

2021-09-11

Mya Myat Ngwe Tun

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

Articles/Books

2021-09-03

Toru Takenaga, Zihan Zhang, Yukiko Muramoto, et al.

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

Others

2021-08-01

Yuki Takamatsu

Yuki Takamatsu has been accepted for AMED 2021 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic) pathogen

Paper

Seroepidemiological surveys of tick-borne encephalitis virus and novel tick-borne viruses in wild boar in Nagasaki, Japan

Facilitating the deployment of Japanese human resources for responding global outbreaks of emerging and Re-emerging infectious diseases: A cross-sectional study

Pre-existing neutralizing activity to SARS-CoV-2 in Vietnam prior to COVID-19 pandemic, 2014-2019.

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.

Evidence of Chikungunya virus seroprevalence in Myanmar among Dengue suspected patients and healthy volunteers in the years 2013, 2015 and 2018.

A simple and high-throughput alternative virus assay in the serologic diagnosis of mosquito-borne flavivirus infections.

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

Yuki Takamatsu has been accepted for AMED 2021 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic) pathogen